Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center clinical trial utilizing engineered t-cell therapy similar…
(877) 363-6376
HELPLINE
Intro Dr. Patrick Forde, MD, is leading the charge in a new clinical trial investigating the effectiveness of immunotherapy in patients who are surgical candidates.…
When it comes to dealing with a mesothelioma diagnosis and its treatment, patients and their physicians are faced with many decisions. Recently, the Mesothelioma Applied…
MesoTV, the informational program by the Mesothelioma Applied Research Foundation, is now available also as a podcast. When unable to watch, patients and their families…
We have heard this story from our patients over and over again: after their diagnosis, the patient and their family are catapulted into an intensive…
This episode of MesoTV tackles the topic of managing pain caused by mesothelioma or its treatment. Four experts from the Baylor College of Medicine discuss pain management and ways mesothelioma patients…
The International Mesothelioma Interest Group (iMig) biannual meeting kicked off in earnest today with its 2021 virtual program. The conference was initially slated to take…
As part of its patient support services, the Mesothelioma Applied Research Foundation provides an array of support groups. Some are administered over the phone while…
The Meso Foundation announced today the addition of its new communications manager. Tobias Rodriguez has joined the organization and in this role he will work…
A phase 3 randomized clinical trial looking into the efficacy of combination chemotherapy with immunotherapy is now open in the United States and Australia. How…